Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
18.44
-0.65 (-3.40%)
At close: Jul 24, 2026, 4:00 PM EDT
18.19
-0.25 (-1.38%)
After-hours: Jul 24, 2026, 7:36 PM EDT

Relay Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
10.6815.3610.0125.551.383.03
Revenue Growth
39.04%53.44%-60.83%1749.82%-54.41%-96.34%
Gross Profit
10.6815.3610.0125.551.383.03
Operating Income
-296.46-302.74-372.47-373-299.28-364.7
Net Income
-272.71-276.48-337.71-341.97-290.51-363.87
Earnings Per Share
-1.57-1.61-2.36-2.79-2.59-3.82
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
642.07554.52781.32750.09998.92958.07
Total Debt
31.5732.4648.553.4757.7422.9
Net Cash (Debt)
610.5522.06732.82696.62941.18935.17
Net Cash Growth
-7.95%-28.76%5.20%-25.98%0.64%43.07%
Net Cash Per Share
3.503.045.135.688.399.83

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-213.36-235.46-249.11-300.32-229.49-74.41
Capital Expenditures
-0.03-0.41-2.02-4.13-9.06-3.47
Free Cash Flow
-213.38-235.87-251.13-304.44-238.55-77.88
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-2776.60%-1971.59%-3722.07%-1460.11%-21670.90%-12040.20%
Pretax Margin
-2554.14%-1800.58%-3374.72%-1338.66%-21036.13%-12012.94%
Profit Margin
-2554.14%-1800.58%-3374.72%-1338.66%-21036.10%-12012.90%
FCF Margin
-1998.53%-1536.08%-2509.49%-1191.74%-17273.90%-2571.05%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
376.4395.7969.0754.931310.221097.11